EUVIMEDEUVIMED entdecken
Crossref

Motor Cortex Disinhibition Is Dissociated from Clinical Motor Features in Parkinson's Disease: Longitudinal Evidence

Claudia Ammann iD, Cristina Pagge iD, Emmanuelle Wilhelm iD, Chiara Galletti, Michele Dileone, Michele Matarrazzo iD, Agustina Ruiz-Yanzi iD, Mariana H G Monje iD, Álvaro Sánchez-Ferro iD, Jorge U Máñez-Miró, Raul Martínez-Fernández iD, Fernando Alonso-Frech und 5 weitere

Movement Disorders · 30.10.2026

DOI: 10.1002/mds.70517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 30.10.2026. Verfasst von Claudia Ammann und 16 weiteren Autor:innen. Beteiligte Einrichtung: HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033), European Regional Development Fund of the European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Parkinson's disease, motor dysfunction largely reflects dopamine‐dependent pathophysiological alterations and compensatory mechanisms that progress over time and are partially reversible with dopaminergic treatment. Our recent cross‐sectional observations suggest that disinhibition of the primary motor cortex—assessed with short‐interval intracortical inhibition (SICI) using transcranial magnetic stimulation—does not correlate with clinical motor features, does not progress across disease stages, and instead correlates with olfactory dysfunction, a common prodromal and dopamine‐independent feature.

Objective

We aimed to provide longitudinal evidence for or against the hypothesis that motor cortex disinhibition is dissociated from clinical motor features in Parkinson's disease.

Methods

We compared SICI across three cohorts (total n = 95 patients): (1) baseline and 2‐year follow‐up (n = 43), with concurrent motor assessment and 18 F‐DOPA positron emission tomography (PET) imaging (n = 24); (2) before and after levodopa administration (n = 30); and (3) before and after focused ultrasound subthalamotomy (n = 22). We also included a pooled healthy control group (n = 75) from two previously published studies. Bayesian statistics was applied to formally assess evidence for the presence or the absence of an effect.

Results

SICI was expectedly reduced, with very strong to extreme Bayesian evidence, in patients compared with control subjects. We found evidence that cortical disinhibition did not worsen with clinically evident disease progression confirmed with 18 F‐DOPA PET and did not improve following a clinically effective dose of levodopa or subthalamotomy. Moreover, changes in SICI did not correlate with changes in motor features across cohorts.

Conclusions

These findings provide longitudinal evidence that motor cortex disinhibition is largely dissociated from clinical motor features in Parkinson's disease. © 2026 International Parkinson and Movement Disorder Society.

Schlagwörter

Stichwörter der Autor:innen

Parkinson’s diseasecortical disinhibitionmotor cortexshort‐interval intracortical inhibition (SICI)transcranial magnetic stimulation (TMS)

Autor:innen und Institutionen

  • HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
  • Faculty of Health Sciences - HM Hospitales, University Camilo José Cela, Madrid, Spain.
  • Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain.
  • Universidad de Alcalá, Madrid, Spain.
  • Research Unit, Neurology, Hospital Virgen del Puerto, FundeSalud, Plasencia, Spain.
  • Faculty of Health Sciences, UCLM, Talavera de la Reina, Spain.

ORCID-Profile: Claudia Ammann, Cristina Pagge, Emmanuelle Wilhelm, Michele Matarrazzo, Agustina Ruiz-Yanzi, Mariana H G Monje, Álvaro Sánchez-Ferro, Raul Martínez-Fernández, Miguel López-Aguirre, José A Pineda-Pardo, Antonio Oliviero, Guglielmo Foffani

Förderung

  • Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033)
  • European Regional Development Fund of the European Union

Zitieren

APA

Ammann, C., Pagge, C., Wilhelm, E., Galletti, C., Dileone, M., Matarrazzo, M., Ruiz-Yanzi, A., Monje, M. H. G., Sánchez-Ferro, Á., Máñez-Miró, J. U., Martínez-Fernández, R., Alonso-Frech, F., López-Aguirre, M., Pineda-Pardo, J. A., Oliviero, A., Obeso, J. A., & Foffani, G. (2026). Motor Cortex Disinhibition Is Dissociated from Clinical Motor Features in Parkinson's Disease: Longitudinal Evidence. Movement Disorders. https://doi.org/10.1002/mds.70517

Vancouver

Ammann C, Pagge C, Wilhelm E, Galletti C, Dileone M, Matarrazzo M, et al. Motor Cortex Disinhibition Is Dissociated from Clinical Motor Features in Parkinson's Disease: Longitudinal Evidence. Movement Disorders. 2026. doi:10.1002/mds.70517

BibTeX
@article{Ammann2026,
  author = {Ammann, Claudia and Pagge, Cristina and Wilhelm, Emmanuelle and Galletti, Chiara and Dileone, Michele and Matarrazzo, Michele and Ruiz-Yanzi, Agustina and Monje, Mariana H G and Sánchez-Ferro, Álvaro and Máñez-Miró, Jorge U and Martínez-Fernández, Raul and Alonso-Frech, Fernando and López-Aguirre, Miguel and Pineda-Pardo, José A and Oliviero, Antonio and Obeso, José A and Foffani, Guglielmo},
  title = {Motor Cortex Disinhibition Is Dissociated from Clinical Motor Features in Parkinson's Disease: Longitudinal Evidence},
  journal = {Movement Disorders},
  year = {2026},
  doi = {10.1002/mds.70517}
}
Kostenlos starten →